EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model.

Antimicrobial Agents and Chemotherapy
Ray HachemIssam I Raad

Abstract

Rats immunosuppressed by the administration of cyclophosphamide and cortisone acetate and then infected with Aspergillus fumigatus were treated with an antifungal drug, EDTA, or a combination of one of the antifungal agents, amphotericin B lipid complex (ABLC; 5 mg/kg of body weight/day for 7 days), and EDTA (30 mg/kg/day for 7 days). The mortality rate was reduced, the duration of survival was increased, fewer A. fumigatus organisms were recovered from the lungs, and less-severe lung lesions were seen histopathologically in the rats receiving the combination treatment than in the rats receiving either an antifungal agent or EDTA alone. Further studies regarding the mechanisms of EDTA and its interactions with ABLC are warranted, and further studies are needed to more fully examine the safety, tolerance, and optimal dosing of EDTA in the treatment of this and other fungal infections.

References

Nov 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V T Andriole
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Nov 15, 2000·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·B H SenA A Denizci
Jan 25, 2002·The New England Journal of Medicine·Thomas J WalshUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Jun 28, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ana I Sánchez-FructuosoAlberto Barrientos
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Sep 16, 2003·The Journal of Antimicrobial Chemotherapy·John R GraybillLaura K Najvar
Nov 14, 2003·The Journal of Antimicrobial Chemotherapy·María Teresa MartínAlbert Pahissa
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensUNKNOWN Caspofungin Salvage Aspergillosis Study Group

❮ Previous
Next ❯

Citations

Aug 6, 2008·Annual Review of Phytopathology·Hubertus HaasB Gillian Turgeon
Nov 13, 2007·Annals of Clinical Microbiology and Antimicrobials·Guo-Xian WeiLibuse A Bobek
Jun 2, 2012·Journal of Biomedicine & Biotechnology·Philippe JeandetEric Courot
Aug 30, 2008·Molecular Microbiology·Markus SchrettlHubertus Haas
Dec 17, 2009·Mycoses·Anthony J De LuccaThomas J Walsh
Jan 3, 2015·Fungal Genetics and Biology : FG & B·Fei-fei LiuLing Lu
Mar 17, 2015·Frontiers in Microbiology·Rocío VicentefranqueiraJosé A Calera
Feb 15, 2018·Antimicrobial Agents and Chemotherapy·Karen A O'Hanlon CohrtAnne-Marie Lund Winther
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Paris LaskarisOumaima Ibrahim-Granet
Jun 1, 2017·Frontiers in Microbiology·Guillaume Desoubeaux, Carolyn Cray
Jun 21, 2014·Mycopathologia·Jorge Amich, José Antonio Calera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.